Skip to content
+1 925 830 1000
Toggle Navigation
Toggle Navigation
Home
Heart Failure
Revivent Therapy
RELIVE Trial
About
Our Company
Press Releases
Publications
Resource Library
Contact
Toggle Navigation
Home
Heart Failure
Revivent Therapy
RELIVE Trial
About
Our Company
Press Releases
Publications
Resource Library
Contact
Patient Identification
Michael
2025-12-11T15:32:41-05:00
Patient Identification
Target Patient Population (NYHA III-IV)
Previous myocardial infarction (90 days or more) with scar (ischemic)
Scar
Anteroseptal, apical, and/or anterolateral region
Discrete acontractile (akinetic and/or dyskinetic)
Transmural (>50%)
Dilation
Must include LV dilation or aneurysm
Viable Myocardium
Is required at the base for implant
Page load link
Go to Top